Scarica l'app Stockscreener
6.41
2.40%
0.15
Precedente Chiudi:
$6.26
Aprire:
$6.35
Volume 24 ore:
398.52K
Relative Volume:
1.18
Capitalizzazione di mercato:
$500.96M
Reddito:
$14.02M
Utile/perdita netta:
$-84.03M
Rapporto P/E:
-4.3605
EPS:
-1.47
Flusso di cassa netto:
$-125.54M
1 W Prestazione:
+11.09%
1M Prestazione:
+4.23%
6M Prestazione:
+45.02%
1 anno Prestazione:
+4.74%
Intervallo 1D:
$6.14
$6.46
Intervallo di 1 settimana:
$5.66
$6.65
Portata 52W:
$3.85
$7.37
Meiragtx Holdings Plc Stock (MGTX) Company Profile
Nome
Meiragtx Holdings Plc
Settore
Industria
Telefono
646-860-7985
Indirizzo
450 EAST 29TH STREET, NEW YORK, NY
Confronta MGTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MGTX
Meiragtx Holdings Plc
|
6.41 | 500.96M | 14.02M | -84.03M | -125.54M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-31 | Ripresa | Chardan Capital Markets | Buy |
| 2020-10-23 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-09-15 | Ripresa | BofA Securities | Buy |
| 2019-09-03 | Iniziato | Piper Jaffray | Overweight |
| 2019-02-27 | Reiterato | Chardan Capital Markets | Buy |
| 2018-07-03 | Iniziato | Barclays | Overweight |
| 2018-07-03 | Iniziato | BofA/Merrill | Buy |
Mostra tutto
Meiragtx Holdings Plc Borsa (MGTX) Ultime notizie
MeiraGTX CFO Richard Giroux sells $150,960 in ordinary shares - Investing.com India
Long Term Trading Analysis for (MGTX) - Stock Traders Daily
Is MeiraGTx Holdings plc (MGTX) Among Billionaire Joseph Edelman’s Long-Term Stock Picks? - Insider Monkey
MeiraGTx (NASDAQ:MGTX) Trading 8% HigherWhat's Next? - MarketBeat
Barclays PLC Acquires 76,437 Shares of MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Acquired by Barclays PLC - MarketBeat
MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Sold by Jane Street Group LLC - Defense World
Contrasting Innate Pharma (OTCMKTS:IPHYF) and MeiraGTx (NASDAQ:MGTX) - Defense World
MeiraGTx Holdings plc (NASDAQ:MGTX) CEO Sells $231,878.33 in Stock - MarketBeat
MeiraGTX president sells shares worth $305,342 By Investing.com - Investing.com Nigeria
Head-To-Head Survey: Tevogen Bio (NASDAQ:TVGN) and MeiraGTx (NASDAQ:MGTX) - Defense World
Geode Capital Management LLC Cuts Position in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
High Growth Tech Stocks in the United States - Simply Wall St
MeiraGTx Holdings plc (NASDAQ:MGTX) Stock Holdings Lifted by Barclays PLC - Defense World
State Street Corp Boosts Stake in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
How the (MGTX) price action is used to our Advantage - Stock Traders Daily
MeiraGTx Holdings plc (MGTX): Is This Gene Therapy Stock a Good Buy Right Now? - Insider Monkey
(MGTX) Trading Signals - Stock Traders Daily
MeiraGTx (NASDAQ:MGTX) Shares Up 10.1%Here's Why - MarketBeat
BNP Paribas Financial Markets Raises Stock Holdings in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
MeiraGTx's SWOT analysis: gene therapy firm's stock faces clinical hurdles - Investing.com
Garden State Investment Advisory Services LLC Invests $1.64 Million in MeiraGTx Holdings plc (NASDAQ:MGTX) - MarketBeat
Investors in MeiraGTx Holdings (NASDAQ:MGTX) have unfortunately lost 71% over the last five years - Yahoo Finance
MetLife Investment Management LLC Reduces Position in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
MeiraGTx's SWOT analysis: gene therapy firm's stock faces pivotal year By Investing.com - Investing.com Nigeria
MeiraGTx granted RMAT designation by U.S. FDA to AAV2-hAQP1 - Yahoo Finance
Learn to Evaluate (MGTX) using the Charts - Stock Traders Daily
FDA grants RMAT status to MeiraGTx's xerostomia gene therapy By Investing.com - Investing.com Canada
MeiraGTx Holdings plc (MGTX) Receives RMAT Designation from FDA for AAV2-hAQP1 - Defense World
FDA grants RMAT status to MeiraGTx's xerostomia gene therapy - Investing.com India
MeiraGTx Secures Coveted FDA RMAT Status for Breakthrough Xerostomia Gene Therapy - StockTitan
MeiraGTx Holdings: Behind The Recent Rally (NASDAQ:MGTX) - Seeking Alpha
Erste Asset Management GmbH Takes $2.80 Million Position in MeiraGTx Holdings plc (NASDAQ:MGTX) - MarketBeat
MeiraGTx (NASDAQ:MGTX) Shares Gap UpHere's Why - MarketBeat
Knoll Capital Management LLC Buys Shares of 1,250,000 MeiraGTx Holdings plc (NASDAQ:MGTX) - MarketBeat
Chardan Capital Reiterates Buy Rating for MeiraGTx (NASDAQ:MGTX) - Defense World
Trend Tracker for (MGTX) - Stock Traders Daily
Analysts Have Lowered Expectations For MeiraGTx Holdings plc (NASDAQ:MGTX) After Its Latest Results - Simply Wall St
MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance
MeiraGTx Holdings Reports Significant Losses Amid Strategic Moves - TipRanks
MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Tops Revenue Estimates - MSN
MeiraGTx wins 3 Rare Pediatric designations and updates on AAV-AIPL1 - The Pharma Letter
MeiraGTx Holdings plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
MeiraGTx Holdings PLC Q3 2024 Earnings: Revenue Soars to $10.9M, EPS Misses Estimates at -$0.55 - GuruFocus.com
MeiraGTx Scores Triple FDA Designations, Reports Strong Parkinson's Data Despite Q3 Loss | MGTX Stock News - StockTitan
Jim Cramer: This Tech Stock Is A Buy, SoFi Technologies Is Good - Benzinga
Dynamic range: the key to MeiraGTx’s quest to control genes with pills - BioCentury
Duchenne Muscular Dystrophy Therapeutics Market Trends, Growth Insights, and Forecasts 2033 - WhaTech
Gene Therapy Market Detailed Analysis and Forecast to 2031 - InsightAce Analytic
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity - BioWorld Online
MeiraGTx Announces Five Posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual Congress - The Manila Times
Meiragtx Holdings Plc Azioni (MGTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.81%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):